Top 2 Risk Off Stocks That May Plunge This Quarter Two consumer staples stocks signal warning to momentum-based investors. RSI indicator shows overbought conditions for Olaplex and Darling Ingredients.
The 1 Reason Arista Networks Is Quietly Winning the AI Race in 2026 This AI infrastructure player is quietly powering the networks in large data centers.
What's Going On With Alphabet Stock Friday? Alphabet Inc. (
NASDAQ: GOOGL ) shares fell in Friday's premarket session. This follows a 3.44% decline during Thursday's regular trading.
Top 3 Real Estate Stocks That Could Blast Off In March Opportunity to buy undervalued real estate stocks with RSI near or below 30. Oversold companies include AHR, SITC, and O with recent stock decreases and low RSI values.
AstraZeneca Zips Higher On Its Double Win In COPD Treatment AstraZeneca stock jumped Friday after the U.K.-based drugmaker said its COPD drug succeeded in two final-phase studies.
Stocks making big moves this week: Shopify, Winnebago, Coinbase, STAAR Surgical, and Viavi Solutions Check out the companies making headlines this week: Shopify (
NASDAQ:SHOP ): E-commerce platform Shopify (
NYSE:SHOP ) rose by 3.8% on Monday after comments from...
Why Gemini Space Station Stock Declined 23% This Week The analyst community turned more negative on the stock this week.
Greenland Energy Stock Climbs Following Merger Completion, Nasdaq Debut Greenland Energy Company (
NASDAQ:GLND ) shares are trading higher amid volatility following its merger with Pelican Acquisition Corporation.
Meta Stock: What's Next After 'Big Tobacco Moment' Fears Fuel Sell-Off? Meta stock lost $119 billion in market cap after court losses prompted fears that social media is facing a Big Tobacco style legal reckoning.
Rapid7 Buys Kenzo Security To Launch Autonomous AI Security Operations Rapid7 acquires Kenzo Security to boost AI-driven cybersecurity, speed up investigations, and expand alert coverage across systems.
AstraZeneca Strengthens Position In COPD Race With Successful Trials AstraZeneca reports Phase 3 success for tozorakimab in COPD, reducing exacerbations and showing strong safety across broad patient groups.
Why FMC Corporation Rallied 20% This Week In a bad week for the markets, this beaten-down chemicals company got a lift from Wall Street.
Why Is Veritone Stock Tanking Friday? VERI stock drops in premarket trading. Veritone slashes revenue outlook and projects a wider-than-expected EPS loss for fiscal 2025.
Elizabeth Warren Blasts Fed Chair Nominee Kevin Warsh, Calls Him A 'Rubber Stamp' For Trump In New Letter Sen. Elizabeth Warren criticizes Fed nominee Kevin Warsh as a "rubber stamp" for Trump's Wall Street agenda, while political hurdles and economic challenges complicate his confirmation.
8 Stocks I'd Buy if I Were Starting a Tech Portfolio From Scratch Today These eight stocks will form a great foundation for a top tech stock portfolio.
Best States to Retire for Retirees in the U.S. in 2026 Three states rose above the rest, and the winner probably won't surprise you.
What's Going On With Onconetix Shares On Friday? Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 reverse split.
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.
Novo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin FDA approves Novo Nordisk once-weekly insulin Awiqli for Type 2 diabetes, offering an alternative to daily injections.
Meta, Netflix, CrowdStrike And More On CNBC's 'Final Trades' Rob Sechan named Meta Platforms as his final trade on CNBC's Halftime Report, as the company faces legal issues and job cuts.
